ESOPMay 28, 2026, 08:32 AM
Ascentage Pharma Trustee Buys 100,000 Shares for RSU Scheme for HK$3.98M
AI Summary
Ascentage Pharma Group International announced that its Trustee purchased 100,000 existing shares on-market on May 27, 2026. These shares were acquired for the purpose of the 2022 RSU Scheme to satisfy Restricted Share Units upon vesting. The total consideration for this purchase was HK$3,977,000, at an average price of approximately HK$39.77 per share. Following this transaction, the Trustee now holds a total of 2,265,000 shares for the scheme.
Key Highlights
- Ascentage Pharma's Trustee purchased 100,000 shares on May 27, 2026, for the 2022 RSU Scheme.
- The total consideration for the purchased shares was HK$3,977,000.
- The average consideration per purchased share was approximately HK$39.77.
- The purchased shares represent approximately 0.0268% of the total issued shares.
- Following this transaction, the Trustee holds a total of 2,265,000 shares for the RSU Scheme.
- The Trustee will not exercise the voting rights attached to the shares held on trust.
Price Impact
More from AAPG